Where I see patients (1)
My reviews
Selected research
-
Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls.
Multiple sclerosis (Houndmills, Basingstoke, England)
-
Cognitive Function in People With Pediatric Multiple Sclerosis Over 2 Years.
Neurology
-
Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry.
Journal of child neurology
4.9